Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 22:58:103223.
doi: 10.1016/j.pmedr.2025.103223. eCollection 2025 Oct.

Prevalence of human T-cell lymphotropic virus type 1 or 2 among blood donors screened at the New Zealand Blood Service: An observational study, 2001-2024

Affiliations

Prevalence of human T-cell lymphotropic virus type 1 or 2 among blood donors screened at the New Zealand Blood Service: An observational study, 2001-2024

Phyu Sin Aye et al. Prev Med Rep. .

Abstract

Objective: To investigate prevalence of Human T-cell Lymphotropic Virus type 1 or 2 (HTLV-1/2) using the New Zealand Blood Service (NZBS) data, to inform whether further HTLV-1/2 prevalence study may be required, in the context of drivers of the inequities in lung cancer for Māori (the Indigenous population).

Methods: This observational cross-sectional study used the NZBS data of all blood donors nationwide (01/01/2001-30/06/2024). Prevalence overall and by ethnicity was calculated as the number of confirmed HTLV-1/2 positive cases per 10,000 donors.

Results: Of 679,946 new donors over the 23.5 years, 25 HTLV-1/2 positive cases were identified. The overall prevalence of HTLV-1/2 in New Zealand was 0.4 cases per 10,000 donors, highest among Middle Eastern, Latin American and African ethnicity (six cases per 10,000 donors), with no positive cases in Māori and Pacific donors. Among the positive cases, the highest proportions were seen separately for those aged 25-34, females, of New Zealand European ethnicity, resident in Auckland, and born in India, compared to their counterparts.

Conclusions: Prevalence of HTLV-1/2 infection among blood donors in New Zealand was very low, with no evidence of infection among Māori and Pacific donors, suggesting that a wider HTLV-1/2 seroprevalence study was unlikely to be necessary.

Keywords: Blood donor; HTLV; Human T-cell Lymphotropic virus; New Zealand; Prevalence.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.

References

    1. Ciminale V., Rende F., Bertazzoni U., Romanelli M.G. HTLV-1 and HTLV-2: highly similar viruses with distinct oncogenic properties. Front. Microbiol. 2014;5(JULY):398. doi: 10.3389/FMICB.2014.00398. - DOI - PMC - PubMed
    1. Cormack Donna, McLeod M Improving and Maintaining Quality in Ethnicity Data Collections in the Health and Disability Sector. 2010. www.ethnicity.maori.nz Accessed April 24, 2023.
    1. Einsiedel L., Pham H., Wilson K., et al. Human T-Lymphotropic virus type 1c subtype proviral loads, chronic lung disease and survival in a prospective cohort of indigenous Australians. PLoS Negl. Trop. Dis. 2018;12(3) doi: 10.1371/JOURNAL.PNTD.0006281. - DOI - PMC - PubMed
    1. Einsiedel L., Chiong F., Jersmann H., Taylor G.P. Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection. Retrovirology. 2021;18(1):1–13. doi: 10.1186/S12977-020-00543-Z/FIGURES/1. - DOI - PMC - PubMed
    1. Einsiedel L., Pham H., Talukder M.R., et al. Very high prevalence of infection with the human T cell leukaemia virus type 1c in remote Australian aboriginal communities: results of a large cross-sectional community survey. PLoS Negl. Trop. Dis. 2021;15(12) doi: 10.1371/JOURNAL.PNTD.0009915. - DOI - PMC - PubMed

LinkOut - more resources